Found: 101
Select item for more details and to access through your institution.
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.
- Published in:
- 2001
- By:
- Publication type:
- journal article
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 1, p. 25, doi. 10.1002/ajh.21912
- By:
- Publication type:
- Article
Ethical practice in managed care: a dose of realism.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Physician payment reform: Congress's turn.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Seeking the just price: constructing relative value scales and fee schedules.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression—A single center retrospective study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 628, doi. 10.1111/ejh.14057
- By:
- Publication type:
- Article
Efficacy of venetoclax plus anti‐CD38 monoclonal antibody‐containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 222, doi. 10.1111/ejh.13896
- By:
- Publication type:
- Article
Baseline serum B‐cell maturation antigen levels predict time to disease progression for patients with smoldering multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 318, doi. 10.1111/ejh.13666
- By:
- Publication type:
- Article
Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 6, p. 621, doi. 10.1111/ejh.13058
- By:
- Publication type:
- Article
Monoclonal Gammopathy of Undetermined Significance: Why Identification of These Patients and Assessment of Their Skeletons Is Important.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 4, p. 311, doi. 10.3816/CLM.2009.n.061
- By:
- Publication type:
- Article
Proteasome Inhibitors: Closing the Garbage Can Opens up New Therapeutic Options for Patients with B-Cell Malignancies.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S182
- By:
- Publication type:
- Article
Clinical Utility of Biochemical Markers of Bone Metabolism for Improving the Management of Patients with Advanced Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 5, p. 346
- By:
- Publication type:
- Article
Arsenic Compounds in the Treatment of Multiple Myeloma: A New Role for a Historical Remedy.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 3, p. 192
- By:
- Publication type:
- Article
Attributions for Rejection and Acceptance in Young Adults With Borderline and Avoidant Personality Features.
- Published in:
- Journal of Social & Clinical Psychology, 2018, v. 37, n. 6, p. 431, doi. 10.1521/jscp.2018.37.6.431
- By:
- Publication type:
- Article
The Van Poznak/Estilo Article Reviewed.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 9, p. 1065
- By:
- Publication type:
- Article
Removal of a Silicone Gel Breast Implant in a Multiple Myeloma Patient Improved Disease Status: A Case Report.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 3, p. 1103, doi. 10.1159/000508494
- By:
- Publication type:
- Article
Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 3, p. 1184, doi. 10.3892/ijo.2014.2511
- By:
- Publication type:
- Article
Interference with nuclear factor kappa B and c-Jun NH<sub>2</sub>-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
- Published in:
- Oncogene, 2006, v. 25, n. 49, p. 6520, doi. 10.1038/sj.onc.1209653
- By:
- Publication type:
- Article
Bendamustine: A Review of its Use in the Management of Chronic Lymphocytic Leukaemia, Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma and Multiple Myeloma.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 523, doi. 10.1016/j.clml.2022.01.012
- By:
- Publication type:
- Article
Treatment With Elotuzumab in Combination With Dexamethasone Achieves a Complete Remission in a Previously Treated Patient With Multiple Myeloma: A Case Report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy of Topical Use Crisaborole 2% Ointment for Treatment of Necrobiotic Xanthogranuloma Associated With Multiple Myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Venetoclax in Combination With Bortezomib, Dexamethasone, and Daratumumab for Multiple Myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2).
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Medical Research Council Myeloma IX Trial: New Clinical Insights on the Anticancer Effects of Zoledronic Acid in Patients With Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 1, p. 2, doi. 10.1016/j.clml.2011.03.025
- By:
- Publication type:
- Article
Primary osteogenic sarcoma of the bladder. Case report and review of the literature.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Reward and Punishment Sensitivity in Borderline and Avoidant Personality Disorders.
- Published in:
- Journal of Personality Disorders, 2021, v. 35, n. 4, p. 573, doi. 10.1521/pedi_2020_34_475
- By:
- Publication type:
- Article
Childhood Physical and Emotional Abuse by a Parent: Transference Effects in Adult Interpersonal Relations.
- Published in:
- Personality & Social Psychology Bulletin, 2006, v. 32, n. 11, p. 1509, doi. 10.1177/0146167206291671
- By:
- Publication type:
- Article
Loss of anti‐spike antibodies following mRNA vaccination for COVID‐19 among patients with multiple myeloma.
- Published in:
- Cancer Reports, 2023, v. 6, n. 5, p. 1, doi. 10.1002/cnr2.1803
- By:
- Publication type:
- Article
Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2016, v. 108, n. 3, p. 1, doi. 10.1093/jnci/djv342
- By:
- Publication type:
- Article
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00505-4
- By:
- Publication type:
- Article
Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 7, p. 1529, doi. 10.1038/leu.2014.27
- By:
- Publication type:
- Article
A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 7, p. 1675, doi. 10.1038/leu.2012.51
- By:
- Publication type:
- Article
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 5, p. 1091, doi. 10.1038/leu.2011.312
- By:
- Publication type:
- Article
Sources of the growth in Medicare physician expenditures.
- Published in:
- JAMA: Journal of the American Medical Association, 1992, v. 267, n. 5, p. 687, doi. 10.1001/jama.1992.03480050091031
- By:
- Publication type:
- Article
Phase I/ II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 3, p. 321, doi. 10.1111/bjh.12129
- By:
- Publication type:
- Article
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 6, p. 727, doi. 10.1111/j.1365-2141.2012.09241.x
- By:
- Publication type:
- Article
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 5, p. 580, doi. 10.1111/j.1365-2141.2011.08884.x
- By:
- Publication type:
- Article
Monoclonal gammopathy of undetermined significance: a consensus statement.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 28, doi. 10.1111/j.1365-2141.2010.08207.x
- By:
- Publication type:
- Article
The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 4, p. 569, doi. 10.1111/j.1365-2141.2009.08008.x
- By:
- Publication type:
- Article
Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 4, p. 537, doi. 10.1111/j.1365-2141.2008.07359.x
- By:
- Publication type:
- Article
Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 4, p. 467, doi. 10.1111/j.1365-2141.2007.06675.x
- By:
- Publication type:
- Article
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 2, p. 174, doi. 10.1111/j.1365-2141.2006.06280.x
- By:
- Publication type:
- Article
Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 5, p. 526, doi. 10.1111/j.1365-2141.2006.06052.x
- By:
- Publication type:
- Article
Risk of skin cancer in multiple myeloma patients: a retrospective cohort study.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 5, p. 439, doi. 10.1111/ejh.12748
- By:
- Publication type:
- Article
Vorinostat enhances the antimyeloma effects of melphalan and bortezomib.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 201, doi. 10.1111/j.1600-0609.2009.01384.x
- By:
- Publication type:
- Article
Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 433, doi. 10.1111/j.1600-0609.2009.01244.x
- By:
- Publication type:
- Article
The development of novel targeted therapeutics for treatment of multiple myeloma research roundtable.
- Published in:
- European Journal of Haematology, 2003, v. 70, n. 4, p. 263, doi. 10.1034/j.1600-0609.2003.t01-2-00011.x
- By:
- Publication type:
- Article